Background illustration for clinical trials search

Paid Clinical Trials Vermont

Discover 194 paid clinical trials in Vermont. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia,
Location: Halifax, Portland ME, Scarborough ME, South Portland ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554406

Phase 2, Recruiting

Novel Telemedicine-Delivered Prolonged Exposure Therapy for Treating PTSD in Individuals With OUD

for
Opioid Use Disorder, Posttraumatic Stress Disorder
Location: Burlington VT
Sponsor: University of Vermont

Sex: All

Age: 18+

Code: NCT06288711

Recruiting

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

for
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,
Location: Boston MA, Stoneham MA, Westerly RI, Waterford CT,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT04566328

Phase 3, Recruiting

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Halifax, Portland ME, Scarborough ME, South Portland ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554393

Phase 2, Recruiting

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

for
Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma
Location: Boston MA, Providence RI, Westerly RI, Waterford CT,
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Sex: All

Age: 18+

Code: NCT04031677

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

for
Peritoneal Carcinomatosis
Location: Burlington VT, Lexington KY
Sponsor: Prakash Pandalai

Sex: All

Age: 18+

Code: NCT04779554

Phase 2, Recruiting

Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset

for
Infant, Extremely Premature, Obstetric Labor, Premature,
Location: Boston MA, The Bronx NY, Hackensack NJ, Burlington VT,
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 0 - 1

Code: NCT05685745

Recruiting

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

for
Crohn's Disease
Location: Halifax, Hartford CT, New York NY, Burlington VT,
Sponsor: Eli Lilly and Company

Sex: All

Age: 2 - 17

Code: NCT05509777

Phase 3, Recruiting

Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant Chemotherapy

for
Breast Cancer
Location: Brooklyn, NY, Burlington VT
Sponsor: University of Vermont

Sex: Female

Age: 18+

Code: NCT01612247

Recruiting

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung
Location: Westbrook ME, Worcester MA, Hartford CT, New York NY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06890598

Phase 3, Recruiting

Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer

for
Cancer
Location: Burlington VT
Sponsor: University of Vermont

Sex: All

Age: 18+

Code: NCT01148407

Recruiting

Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy

for
Chemotherapy-induced Peripheral Neuropathy
Location: Burlington VT, Richmond VA, Salt Lake City UT
Sponsor: University of Vermont

Sex: All

Age: 18+

Code: NCT04763356

Recruiting

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

for
Low Grade Astrocytoma, Low Grade Glioma,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2 - 21

Code: NCT04166409

Phase 3, Recruiting

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Boston MA, New Haven CT, Stony Brook NY,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06001788

Phase 1, Recruiting

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Scarborough ME, Boston MA, Providence RI, New Haven CT,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT01790152

Recruiting

USCRI READY4Life Program

for
Communication, Problem Solving, Social Relationships,
Location: Colchester VT, Philadelphia PA, Raleigh NC, Miami FL,
Sponsor: US Committee for Refugees and Immigrants

Sex: All

Age: 14 - 24

Code: NCT05476185

Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT03959085

Phase 3, Recruiting

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

for
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma,
Location: Saint Johnsbury VT, Lebanon NH, New York NY,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05633615

Phase 2, Recruiting

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Brunswick ME, Portland ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06317649

Phase 2, Recruiting

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

for
Acute Myeloid Leukemia,
Location: Halifax, Brunswick ME, Portland ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05564390

Phase 2, Recruiting

Popular cities in Vermont